You are using an outdated browser. Please upgrade your browser to improve your experience.
Lipids & Atherosclerosis

The Clinician’s Handbook- Dyslipidaemia and Atherosclerosis translates recent guidelines for treatment of dyslipidaemia in cardiovascular prevention to an easily accessible and practically oriented handbook to be used in daily clinical practice

The Clinician’s Handbook- Dyslipidaemia and Atherosclerosis translates recent guidelines for treatment of dyslipidaemia in cardiovascular prevention to an easily accessible and practically oriented handbook to be used in daily clinical practice

Lipids & Atherosclerosis

by Abannan Digital Solutions
Lipids & Atherosclerosis
Lipids & Atherosclerosis
Lipids & Atherosclerosis

What is it about?

The Clinician’s Handbook- Dyslipidaemia and Atherosclerosis translates recent guidelines for treatment of dyslipidaemia in cardiovascular prevention to an easily accessible and practically oriented handbook to be used in daily clinical practice. The Handbook is based on the EAS/ESC Joint Guidelines for Management of Dyslipidaemia, 2016, and is endorsed by EAS and ESC.

Lipids & Atherosclerosis

App Details

Version
2.1.0
Rating
NA
Size
38Mb
Genre
Medical
Last updated
June 25, 2018
Release date
January 2, 2014
More info

App Screenshots

Lipids & Atherosclerosis screenshot-0
Lipids & Atherosclerosis screenshot-1
Lipids & Atherosclerosis screenshot-2
Lipids & Atherosclerosis screenshot-3
Lipids & Atherosclerosis screenshot-4

App Store Description

The Clinician’s Handbook- Dyslipidaemia and Atherosclerosis translates recent guidelines for treatment of dyslipidaemia in cardiovascular prevention to an easily accessible and practically oriented handbook to be used in daily clinical practice. The Handbook is based on the EAS/ESC Joint Guidelines for Management of Dyslipidaemia, 2016, and is endorsed by EAS and ESC.

To give a good background for the practical use of guidelines this handbook gives a brief summary of lipoprotein metabolism and the role of lipids and lipoproteins in the pathophysiology of atherosclerosis.
In a comprehensive way the Handbook discusses which lipids should be analysed for CVD risk estimation. Furthermore the different forms of hyperlipidaemia and their pathophysiological background is described. The role of lifestyle and genetic background for the development of dyslipidaemia is emphasized. The content also summarizes the lifestyle and pharmacological options for treatment and the treatment targets for different groups of patients.

This updated edition of the Handbook includes the changes made in the 2016 version of the EAS/ESC guidelines. This for example includes the changed position of ezetimibe after the IMPROVE-IT trial, the new developments of the PCSK9-inhibitors and recent advances in the management of familial hypercholesterlaemia. The Handbook also discusses the importance of treatment targets and the scientific background for lower targets in selected groups of patients.
Authored by leading experts in the field, the Handbook should be an invaluable and accessible resource for both primary and secondary care clinicians.

The development of the handbook was supported by an Unrestricted Educational Grant from SANOFI and REGENERON.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.